Model of Veterinary Infectious Disease Organization (VIDO)

Exterior of the Veterinary Infectious Disease Organization building.

Touring the Vaccine and Infectious Disease Organization (VIDO) facilities are (l to r): R.W. Begg, University President; Dr. Christopher H. Bigland, director of VIDO; and Allan Blakeney, Premier of Saskatchewan.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

Dr. Christopher H. Bigland, dean, Western College of Veterinary Medicine, and Dr. George Khachatourians, professor, Department of Applied Microbiology & Food Science, are seated holding the American patent on bacterial mini-cells developed by the Veterinary Infectious Disease Organization (VIDO).

Note on back: "Jack McFaull (left), of the University Board of Governors, presents the key to the new building housing the Veterinary Infectious Disease Organization (VIDO) to Dr. Chris Bigland, director of VIDO, at the official opening of the new building".

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies.VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

R.W. Begg, University President, speaks from podium during the opening of the Vaccine and Infectious Disease Organization (VIDO). Dignitaries seated are (l to r): M. Moore; Herman Rolfes, Saskatchewan Minister of Continuing Education; and Dr. Chris Bigland, director of VIDO.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

R.W. Begg, University President, speaking from podium during an outdoor ceremony marking the opening of the Veterinary Infectious Disease Organization lab. Attendees seated behind Begg are Dr. Niels O. Nielson, dean, Western College of Veterinary Medicine; W. Weir, E. Kaeding, Dr. Chris Bigland, director of VIDO; and George Shepherd.

Bio/Historical Note: The Vaccine and Infectious Disease Organization (VIDO) is a research organization of the University of Saskatchewan that operates with financial support from the Government of Canada, the government of Saskatchewan, livestock industry councils and agencies, foundations and human and animal health companies. VIDO worked to find cures for common infectious diseases in cattle, swine and poultry. VIDO scientists carved out an international reputation for their pioneering work in the 1980's on vaccines aimed at combating shipping fever and a disease which produces pneumonia and arthritis in cattle. In addition to the 2,500,000 sq ft facility on campus, VIDO-InterVac also operates a 160-acre research station. The laboratory took on its current name, International Vaccine Centre (VIDO-InterVac), in March 2003. In October 2003 a large expansion was completed. In March 2004, VIDO received funding for the construction one of the world's largest and most advanced biosafety level 3 facilities, the International Vaccine Centre (InterVac), for research into emerging and reemerging human and animal diseases. In 2020, VIDO-InterVac began developing a vaccine for SARS-CoV-2 during the COVID-19 pandemic.

This page is with the two pictures of A. (Jock) Robinson, Isaac (Ike) Forbes and J. French Forbes who are retired from the Royal North West Mounted Police. This paper explains a little about each man and their career as R.N.W.M.P.

These are two photos, one close shot and one at a distance. The pictures are of A. (Jock) Robinson, Isaac (Ike) Forbes and J. French Forbes who are retired from the Royal North West Mounted Police.

Map, "State of Settlement Veteran's Land Act, Saskatchewan", in file 1724-B, Ottawa, unknown date.

Veterans group descending stairway of monument dedicated "A la Victoire et aux Soldats de Verdun", with l'Arc de Triomphe torch which is returning to Paris, during Remembrance Day ceremonies in honour of the 40th Anniversary of Armistice Day, Verdun, France.

Snapshot of a lone veteran looking down upon a grave marker. Taken in an unidentified First World War cemetery in France during John Diefenbaker's pilgrimage to Vimy, circa 1936.

Evan Orchard; Jane Kerr; Carla Hicks